| |
|
|
|
|
|
|
|||
|
Blood, 1 September 2006, Vol. 108, No. 5, pp. 1643-1651. Prepublished online as a Blood First Edition Paper on May 4, 2006; DOI 10.1182/blood-2006-02-006361.
IMMUNOBIOLOGY Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transferFrom the Groupe Virus et Immunité, Unité de Recherche Associée (URA) Centre National de la Recherche Scientifique (CNRS) 1930, Paris; Unité d'Immunité Cellulaire Antivirale, Institut Pasteur, Paris; and IDM Research Laboratories, Institut des Cordeliers, Paris, France.
Human immunodeficiency virus (HIV)-specific CD4+ lymphocytes are preferentially infected in HIV-positive individuals. To study this preferential infection, we have derived several HIV-specific (HS) CD4+ clones. We show that in dendritic cells (DCs), HIV virion capture led to major histocompatibility complex class-II (MHC-II)-restricted viral antigen presentation and to activation of HS cells. In contrast, neither cell-free virions nor infected lymphocytes activated HS cells. In DCs, the dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN/CD209), which internalizes virions, promoted MHC-II presentation of HIV antigens. Activation of HS cells by HIV-exposed DCs triggered an efficient viral spread in lymphocytes. CD4+ clones with irrelevant antigenic specificities were not activated by HIV-exposed DCs and poorly supported viral replication under this setting. Our results unravel the mechanisms of MHC-II-restricted HIV antigen presentation by DCs and describe how HIV gains access to the very cells designed by the immune system to counteract this pathogen.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||